Recombinant Treponema pallidum p17 protein (ab43053)

製品の概要

  • 製品名Recombinant Treponema pallidum p17 protein
  • タンパク質長Protein fragment

製品の詳細

  • 由来Recombinant
  • 由来Escherichia coli
  • アミノ酸配列
    • 配列の追加情報The protein contains the Tr.pallidum p17 immunodominant regions.

特性

Our Abpromise guarantee covers the use of ab43053 in the following tested applications.

The application notes include recommended starting dilutions; optimal dilutions/concentrations should be determined by the end user.

  • 生理活性Immunoreactive with sera of Tr.pallidum - infected individuals.
  • アプリケーション

    ELISA

    Western blot

  • 精製度> 90 % SDS-PAGE.
    Inclusion bodies.
  • 製品の状態Liquid
  • Concentration information loading...

前処理および保存

  • 保存方法および安定性

    Shipped at 4°C. Upon delivery aliquot and store at -20°C. Avoid freeze / thaw cycles.

    Preservative: None
    Constituents: 8M Urea, 10mM Tris HCl, 1mM EDTA, 1mM DTT, pH 8

関連情報

  • 関連性Syphilis is a chronic, complex sexually transmitted disease of humans caused by the spirochetal bacterium Treponema pallidum. Primary syphilis is characterized by the prevalence of IgG to protein p41 with the total antibody level being low, while early latent syphilis is characterized mainly by prevalence of IgG to protein p17 in the presence of high titers of antibodies.
  • 細胞内局在Cell Membrane

Recombinant Treponema pallidum p17 protein (ab43053) 使用論文

ab43053 has not yet been referenced specifically in any publications.

Product Wall

There are currently no Abreviews or Questions for ab43053.
Please use the links above to contact us or submit feedback about this product.

Please note: All products are "FOR RESEARCH USE ONLY AND ARE NOT INTENDED FOR DIAGNOSTIC OR THERAPEUTIC USE"